Patrin Pharma, Inc
Form 483 issued May 6, 2019 · Niles, Illinois
- Inspection
- May 2 – May 6, 2019
- Investigator
- Emma R. Schaefer
- Observations
- 5
- Pages
- 4
- FEI number
- 3006557630
In short: On May 6, 2019, FDA issued a Form 483 with 5 observations to Patrin Pharma, Inc in Niles, Illinois (FEI 3006557630) after an inspection that ran May 2 – May 6, 2019. The investigator was Emma R. Schaefer. Most observations concern cAPA and production & process controls.
At a glance
CAPA and production & process controls account for 3 of 5 observations.
What FDA observed
Preview: the opening words of each observation- 01
Requirements that must be met by suppliers and contractors…
- 02
Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have…
- 03
Procedures for corrective and preventive action…
- 04
Procedures for quality audits have…
This inspection in context
Emma R. Schaefer
4 documents · 2018–2021
Cites 820.50 (purchasing controls) more than any other section. Most of their documents are for sites in Illinois.
The firmPatrin Pharma, Inc history
All 2 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sOther sites cited under 820.50(a)
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at Patrin Pharma, Inc?
FDA listed 5 observations on this Form 483, mostly about cAPA, production & process controls and management controls. The opening words of each observation are shown on this page.
Who inspected Patrin Pharma, Inc?
Emma R. Schaefer is named on this Form 483, for the inspection of May 2 – May 6, 2019. Each investigator has a profile showing what they cite most.
When was Patrin Pharma, Inc inspected by FDA?
The inspection ran May 2 – May 6, 2019, and the Form 483 is dated May 6, 2019.
How do I get the full Form 483 for Patrin Pharma, Inc?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.